Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Paratek Pharmaceuticals Inc.
April 26, 2026
Paratek Pharmaceuticals Inc.
Orphan Drug Designation
post-exposure prophylaxis (PEP) of anthrax infection
Disease Area:
Rare Diseases
Source
April 26, 2026
Paratek Pharmaceuticals Inc.
Orphan Drug Designation
treatment of anthrax
Disease Area:
Rare Diseases
Source
Scroll to Top
